Skip to content

Vascular Closure Device in Transcatheter Aortic Valve Replacement

Plug-based Percutaneous Vascular Closure Device in Transcatheter Aortic Valve Replacement

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04392492
Enrollment
1000
Registered
2020-05-18
Start date
2017-01-25
Completion date
2021-01-31
Last updated
2020-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Valve Stenosis

Brief summary

Evaluation of the safety and efficacy of a percutaneous plug-based large-bore vascular closure device for femoral artery closure in an unselected consecutive patient cohort undergoing transcatheter aortic valve implantation in a single-center prospective study.

Interventions

Femoral access site closure using the MANTA closure device

Sponsors

Karolinska University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients undergoing transfemoral TAVI at the Karolinska University Hospital

Exclusion criteria

* Patients undergoing TAVI with access other than transfemoral * Use of closure device other than MANTA

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with major vascular complications6 week follow upMajor vascular access site complications according to the VARC-2 definitions

Secondary

MeasureTime frameDescription
Number of patients with minor vascular complications6 week follow upMinor vascular access site complications according to the VARC-2 definitions
Number of patients with vascular closure device failure6 week follow upPercutaneous vascular closure device failure according to the VARC-2 definitions
Number of patients with life-threatening, disabling or major bleeding6 week follow upLife-threatening, disabling or major bleeding complications according to the BARC definitions

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026